Policy framework for covering preventive services without cost sharing: Saving lives and saving money?

JAMA Internal Medicine

Volumn 176, Issue 8, 2016, Pages 1185-1189

  Chen, Stephanie C ^a   Pearson, Steven D ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVISORY COMMITTEE; BUDGET; COST CONTROL; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; IMMUNIZATION; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; ECONOMICS; FEMALE; GOVERNMENT; HEALTH CARE DELIVERY; INSURANCE; MALE; UNITED STATES;

ADVISORY COMMITTEES; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; INSURANCE COVERAGE; MALE; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PREVENTIVE HEALTH SERVICES; UNITED STATES; UNITED STATES AGENCY FOR HEALTHCARE RESEARCH AND QUALITY;

EID: 84980335348     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.3052     Document Type: Review

References (27)

1. Fendrick AM, Chernew ME. Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment. Am J Manag Care. 2006;12(Spec no): SP5-SP10.
2. The White House. Remarks by the President on Preventive Care. https://www.whitehouse.gov/the-press-office/2012/02/10/remarks-president-preventive-care. Accessed Apr 22, 2015.
3. The Patient Protection and Affordable Care Act, 42U.S.C. § 18001 (2010).
4. Chernew M, Schwartz JS, Fendrick AM. Reconciling Prevention And Value In The Health Care System. Health Affairs Blog: Health Policy Lab. http://healthaffairs.org/blog/2015/03/11/reconciling-prevention-and-value-in-the-health-care-system/Published Mar 11, 2015. Accessed Apr 25, 2015.
5. Welch HG. The Problem With Free Health Care. New York Times. May 1, 2014: A25.
6. Harris RP, Helfand M, Woolf SH, et al;Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3)(suppl):21-35.
7. U.S. Preventive Services Task Force. Procedural Manual. http://www.uspreventiveservicestaskforce.org/Home/GetFile/6/301/procedure-manual-2015/pdf. Accessed March 22, 2016.
8. Smith JC. The structure, role, and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP). Vaccine. 2010;28(suppl 1):A68-A75.
9. Hagan JF, Shaw JS, Dimcam P, eds. Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents. 3rd ed. Elk Grove Village, IL: American Academy of Pediatrics; 2008.
10. National Academy of Sciences, Institute of Medicine, Board on Population Health and Public Health Practice, Committee on Preventive Services for Women. Clinical Preventive Services for Women: Closing the Gaps. Washington: The National Academies Press; 2011.
11. Russell LB. Preventing chronic disease: an important investment, but don't count on cost savings. Health Aff (Millwood). 2009;28(1):42-45.
12. Maciosek MV, Coffield AB, Flottemesch TJ, Edwards NM, Solberg LI. Greater use of preventive services in U.S. health care could save lives at little or no cost. Health Aff (Millwood). 2010;29(9): 1656-1660.
13. Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med. 2006;31(1):52-61.
14. Sawaya GF, Guirguis-Blake J, LeFevre M, Harris R, Petitti D; U.S. Preventive Services Task Force. Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit. Ann Intern Med. 2007;147 (12):871-875.
15. U.S. Advisory Committee on Immunization Practices. Handbook for Developing Evidence-based Recommendations. http://www.cdc.gov/vaccines/acip/recs/grade/downloads/handbook.pdf. Accessed Feb 24, 2016.
16. U.S. Advisory committee on Immunization Practices. Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for HPV Vaccine for Males. http://www.cdc.gov/vaccines/acip/recs/GRADE/hpv-vac-males.html. Accessed Feb 24, 2016.
17. U.S. Preventive Services Task Force. Final Recommendation Statement: Hepatitis C: Screening. http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/hepatitis-c-screening. Accessed March 20, 2016.
18. Chernew ME, Juster IA, Shah M, et al. Evidence that value-based insurance can be effective. Health Aff (Millwood). 2010;29(3):530-536.
19. Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care. 2010;33(8):1872-1894.
20. Evers PD. Pre-emptive virology screening in the pediatric hematopoietic stem cell transplant population: a cost effectiveness analysis. Hematol Oncol Stem Cell Ther. 2013;6(3-4):81-88.
21. Cheng AK, Rubin HR, Powe NR, Mellon NK, Francis HW, Niparko JK. Cost-utility analysis of the cochlear implant in children. JAMA. 2000;284 (7):850-856.
22. Moran AE, Odden MC, Thanataveerat A, et al. Cost-effectiveness of hypertension therapy according to 2014 guidelines. N Engl J Med. 2015; 372(5):447-455.
23. Prosser LA, Stinnett AA, Goldman PA, et al. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med. 2000;132(10): 769-779.
24. Martikainen J, Valtonen H, Pirttilä T. Potential cost-effectiveness of a family-based program in mild Alzheimer's disease patients. Eur J Health Econ. 2004;5(2):136-142.
25. Choudhry NK, Avorn J, Antman EM, Schneeweiss S, Shrank WH. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Health Aff (Millwood). 2007;26(1):186-194.
26. United Healthcare. Financial Impact of the Affordable Care Act. http://www.uhc.com/content/dam/uhcdotcom/en/HealthReform/PDF/Provisions/FinancialImpactACA.pdf. Accessed Oct 20, 2015.
27. Neumann PJ. Why don't Americans use cost-effectiveness analysis? Am J Manag Care. 2004;10(5):308-312.